Compounds > ondansetron
Page last updated: 2024-11-01

ondansetron and Precordial Catch

ondansetron has been researched along with Precordial Catch in 3 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, J1
Ballard, HS1
Bottino, G1
Bottino, J1
Palmer, JB1
Greenstreet, YL1

Other Studies

3 other studies available for ondansetron and Precordial Catch

ArticleYear
Ondansetron and chest pain.
    Emergency medicine journal : EMJ, 2005, Volume: 22, Issue:1

    Topics: Antiemetics; Chest Pain; Humans; Ondansetron

2005
Ondansetron and chest pain.
    Lancet (London, England), 1992, Oct-31, Volume: 340, Issue:8827

    Topics: Aged; Angina Pectoris; Antineoplastic Combined Chemotherapy Protocols; Chest Pain; Female; Humans; M

1992
Ondansetron and chest pain.
    Lancet (London, England), 1992, Dec-05, Volume: 340, Issue:8832

    Topics: Aged; Angina Pectoris; Antineoplastic Agents; Chest Pain; Humans; Neoplasms; Ondansetron; Product La

1992